ID   PDK1_HUMAN              Reviewed;         436 AA.
AC   Q15118; B2R6T1; B7Z937; D3DPD8; E9PD65; Q308M4;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   12-OCT-2022, entry version 195.
DE   RecName: Full=[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial;
DE            EC=2.7.11.2;
DE   AltName: Full=Pyruvate dehydrogenase kinase isoform 1;
DE            Short=PDH kinase 1;
DE   Flags: Precursor;
GN   Name=PDK1; Synonyms=PDHK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=7499431; DOI=10.1074/jbc.270.48.28989;
RA   Gudi R., Bowker-Kinley M.M., Kedishvili N.Y., Zhao Y., Popov K.M.;
RT   "Diversity of the pyruvate dehydrogenase kinase gene family in humans.";
RL   J. Biol. Chem. 270:28989-28994(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Li H., Nong W., Zhou G., Ke R., Shen C., Zhong G., Zheng Z., Liang M.,
RA   Tang Z., Huang B., Lin L., Yang S.;
RL   Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=18541534; DOI=10.1074/jbc.m801765200;
RA   McFate T., Mohyeldin A., Lu H., Thakar J., Henriques J., Halim N.D., Wu H.,
RA   Schell M.J., Tsang T.M., Teahan O., Zhou S., Califano J.A., Jeoung N.H.,
RA   Harris R.A., Verma A.;
RT   "Pyruvate dehydrogenase complex activity controls metabolic and malignant
RT   phenotype in cancer cells.";
RL   J. Biol. Chem. 283:22700-22708(2008).
RN   [8]
RP   INDUCTION BY HYPOXIA.
RX   PubMed=21763680; DOI=10.1016/j.ajpath.2011.05.050;
RA   Lu C.W., Lin S.C., Chien C.W., Lin S.C., Lee C.T., Lin B.W., Lee J.C.,
RA   Tsai S.J.;
RT   "Overexpression of pyruvate dehydrogenase kinase 3 increases drug
RT   resistance and early recurrence in colon cancer.";
RL   Am. J. Pathol. 179:1405-1414(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   CATALYTIC ACTIVITY, FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT
RP   TYR-136; TYR-243 AND TYR-244.
RX   PubMed=22195962; DOI=10.1016/j.molcel.2011.10.015;
RA   Hitosugi T., Fan J., Chung T.W., Lythgoe K., Wang X., Xie J., Ge Q.,
RA   Gu T.L., Polakiewicz R.D., Roesel J.L., Chen G.Z., Boggon T.J., Lonial S.,
RA   Fu H., Khuri F.R., Kang S., Chen J.;
RT   "Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1
RT   is important for cancer metabolism.";
RL   Mol. Cell 44:864-877(2011).
RN   [11]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER PHE-28, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   ROLE IN HYPOXIC TUMOR SURVIVAL.
RX   PubMed=27505672; DOI=10.1016/j.ccell.2016.07.004;
RA   Chae Y.C., Vaira V., Caino M.C., Tang H.Y., Seo J.H., Kossenkov A.V.,
RA   Ottobrini L., Martelli C., Lucignani G., Bertolini I., Locatelli M.,
RA   Bryant K.G., Ghosh J.C., Lisanti S., Ku B., Bosari S., Languino L.R.,
RA   Speicher D.W., Altieri D.C.;
RT   "Mitochondrial Akt regulation of hypoxic tumor reprogramming.";
RL   Cancer Cell 30:257-272(2016).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 30-436 IN COMPLEX WITH THE
RP   INHIBITORS AZD7545 AND DICHLOROACETATE, FUNCTION, SUBUNIT, CATALYTIC
RP   ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=17683942; DOI=10.1016/j.str.2007.07.001;
RA   Kato M., Li J., Chuang J.L., Chuang D.T.;
RT   "Distinct structural mechanisms for inhibition of pyruvate dehydrogenase
RT   kinase isoforms by AZD7545, dichloroacetate, and radicicol.";
RL   Structure 15:992-1004(2007).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-412.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Kinase that plays a key role in regulation of glucose and
CC       fatty acid metabolism and homeostasis via phosphorylation of the
CC       pyruvate dehydrogenase subunits PDHA1 and PDHA2. This inhibits pyruvate
CC       dehydrogenase activity, and thereby regulates metabolite flux through
CC       the tricarboxylic acid cycle, down-regulates aerobic respiration and
CC       inhibits the formation of acetyl-coenzyme A from pyruvate. Plays an
CC       important role in cellular responses to hypoxia and is important for
CC       cell proliferation under hypoxia. Protects cells against apoptosis in
CC       response to hypoxia and oxidative stress. {ECO:0000269|PubMed:17683942,
CC       ECO:0000269|PubMed:18541534, ECO:0000269|PubMed:22195962,
CC       ECO:0000269|PubMed:7499431}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[pyruvate dehydrogenase E1 alpha subunit] = ADP
CC         + H(+) + O-phospho-L-seryl-[pyruvate dehydrogenase E1 alpha subunit];
CC         Xref=Rhea:RHEA:23052, Rhea:RHEA-COMP:13689, Rhea:RHEA-COMP:13690,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.2;
CC         Evidence={ECO:0000269|PubMed:17683942, ECO:0000269|PubMed:22195962,
CC         ECO:0000269|PubMed:7499431};
CC   -!- ACTIVITY REGULATION: Activity is enhanced by binding to the pyruvate
CC       dehydrogenase subunit DLAT. Inhibited by AZD7545; this compound
CC       interferes with DLAT binding and thereby inhibits kinase activity.
CC       Inhibited by dichloroacetate and radicicol.
CC       {ECO:0000269|PubMed:17683942}.
CC   -!- SUBUNIT: Homodimer, and heterodimer with PDK2. Interacts with the
CC       pyruvate dehydrogenase complex subunit DLAT, and is part of the
CC       multimeric pyruvate dehydrogenase complex that contains multiple copies
CC       of pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase
CC       (DLAT, E2) and lipoamide dehydrogenase (DLD, E3).
CC       {ECO:0000269|PubMed:17683942}.
CC   -!- INTERACTION:
CC       Q15118; P05067: APP; NbExp=3; IntAct=EBI-7016221, EBI-77613;
CC       Q15118; P08559: PDHA1; NbExp=2; IntAct=EBI-7016221, EBI-715747;
CC       Q15118; Q16513: PKN2; NbExp=6; IntAct=EBI-7016221, EBI-2511350;
CC       Q15118-1; P31749-1: AKT1; NbExp=2; IntAct=EBI-12562315, EBI-12562306;
CC       Q15118-1; P31751-1: AKT2; NbExp=2; IntAct=EBI-12562315, EBI-12562336;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:22195962}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15118-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15118-2; Sequence=VSP_055172;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in the heart. Detected at
CC       lower levels in liver, skeletal muscle and pancreas.
CC       {ECO:0000269|PubMed:7499431}.
CC   -!- INDUCTION: Up-regulated via the HIF1A signaling pathway in response to
CC       hypoxia. {ECO:0000269|PubMed:21763680}.
CC   -!- PTM: Phosphorylated by constitutively activated ABL1, FGFR1, FLT3 and
CC       JAK2 (in vitro), and this may also occur in cancer cells that express
CC       constitutively activated ABL1, FGFR1, FLT3 and JAK2. Phosphorylation at
CC       Tyr-243 and Tyr-244 strongly increases kinase activity, while
CC       phosphorylation at Tyr-136 has a lesser effect.
CC       {ECO:0000269|PubMed:22195962}.
CC   -!- MISCELLANEOUS: Exposure of cancer cells to severe hypoxia induces
CC       translocation of AKT to the mitochondrion, leading to AKT-mediated
CC       phosphorylation of PDK1 at Thr-346 which supports tumor cell survival
CC       and proliferation during hypoxia. {ECO:0000269|PubMed:27505672}.
CC   -!- SIMILARITY: Belongs to the PDK/BCKDK protein kinase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L42450; AAC42009.1; -; mRNA.
DR   EMBL; DQ234350; ABB29979.1; -; mRNA.
DR   EMBL; AK304388; BAH14173.1; -; mRNA.
DR   EMBL; AK312700; BAG35578.1; -; mRNA.
DR   EMBL; AC018712; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093818; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471058; EAX11173.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11174.1; -; Genomic_DNA.
DR   EMBL; BC039158; AAH39158.1; -; mRNA.
DR   CCDS; CCDS2250.1; -. [Q15118-1]
DR   CCDS; CCDS63059.1; -. [Q15118-2]
DR   PIR; I55465; I55465.
DR   RefSeq; NP_001265478.1; NM_001278549.1. [Q15118-2]
DR   RefSeq; NP_002601.1; NM_002610.4. [Q15118-1]
DR   PDB; 2Q8F; X-ray; 2.03 A; A=30-436.
DR   PDB; 2Q8G; X-ray; 1.90 A; A=30-436.
DR   PDB; 2Q8H; X-ray; 2.00 A; A=30-436.
DR   PDBsum; 2Q8F; -.
DR   PDBsum; 2Q8G; -.
DR   PDBsum; 2Q8H; -.
DR   AlphaFoldDB; Q15118; -.
DR   SMR; Q15118; -.
DR   BioGRID; 111189; 330.
DR   DIP; DIP-29497N; -.
DR   IntAct; Q15118; 283.
DR   MINT; Q15118; -.
DR   STRING; 9606.ENSP00000376352; -.
DR   BindingDB; Q15118; -.
DR   ChEMBL; CHEMBL4766; -.
DR   DrugBank; DB07403; 4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE.
DR   DrugBank; DB08809; Dichloroacetic acid.
DR   DrugCentral; Q15118; -.
DR   GuidetoPHARMACOLOGY; 2915; -.
DR   iPTMnet; Q15118; -.
DR   PhosphoSitePlus; Q15118; -.
DR   BioMuta; PDK1; -.
DR   DMDM; 3183117; -.
DR   EPD; Q15118; -.
DR   jPOST; Q15118; -.
DR   MassIVE; Q15118; -.
DR   MaxQB; Q15118; -.
DR   PaxDb; Q15118; -.
DR   PeptideAtlas; Q15118; -.
DR   PRIDE; Q15118; -.
DR   ProteomicsDB; 19593; -.
DR   ProteomicsDB; 60444; -. [Q15118-1]
DR   Antibodypedia; 4312; 691 antibodies from 39 providers.
DR   DNASU; 5163; -.
DR   Ensembl; ENST00000282077.8; ENSP00000282077.3; ENSG00000152256.14. [Q15118-1]
DR   Ensembl; ENST00000392571.6; ENSP00000376352.2; ENSG00000152256.14. [Q15118-2]
DR   Ensembl; ENST00000410055.5; ENSP00000386985.1; ENSG00000152256.14. [Q15118-1]
DR   GeneID; 5163; -.
DR   KEGG; hsa:5163; -.
DR   MANE-Select; ENST00000282077.8; ENSP00000282077.3; NM_002610.5; NP_002601.1.
DR   UCSC; uc002uhs.5; human. [Q15118-1]
DR   CTD; 5163; -.
DR   DisGeNET; 5163; -.
DR   GeneCards; PDK1; -.
DR   HGNC; HGNC:8809; PDK1.
DR   HPA; ENSG00000152256; Low tissue specificity.
DR   MIM; 602524; gene.
DR   neXtProt; NX_Q15118; -.
DR   OpenTargets; ENSG00000152256; -.
DR   PharmGKB; PA33154; -.
DR   VEuPathDB; HostDB:ENSG00000152256; -.
DR   eggNOG; KOG0787; Eukaryota.
DR   GeneTree; ENSGT01030000234646; -.
DR   HOGENOM; CLU_023861_1_1_1; -.
DR   InParanoid; Q15118; -.
DR   OMA; IGCIDSM; -.
DR   OrthoDB; 1242599at2759; -.
DR   PhylomeDB; Q15118; -.
DR   TreeFam; TF314918; -.
DR   BRENDA; 2.7.11.2; 2681.
DR   PathwayCommons; Q15118; -.
DR   Reactome; R-HSA-204174; Regulation of pyruvate dehydrogenase (PDH) complex.
DR   Reactome; R-HSA-5362517; Signaling by Retinoic Acid.
DR   SignaLink; Q15118; -.
DR   SIGNOR; Q15118; -.
DR   BioGRID-ORCS; 5163; 9 hits in 1114 CRISPR screens.
DR   ChiTaRS; PDK1; human.
DR   EvolutionaryTrace; Q15118; -.
DR   GeneWiki; Pyruvate_dehydrogenase_lipoamide_kinase_isozyme_1; -.
DR   GenomeRNAi; 5163; -.
DR   Pharos; Q15118; Tchem.
DR   PRO; PR:Q15118; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q15118; protein.
DR   Bgee; ENSG00000152256; Expressed in secondary oocyte and 180 other tissues.
DR   ExpressionAtlas; Q15118; baseline and differential.
DR   Genevisible; Q15118; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005967; C:mitochondrial pyruvate dehydrogenase complex; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0004740; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity; IDA:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; IMP:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; TAS:ProtInc.
DR   GO; GO:0097411; P:hypoxia-inducible factor-1alpha signaling pathway; IMP:UniProtKB.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; IMP:UniProtKB.
DR   Gene3D; 1.20.140.20; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR036784; AK/P_DHK_N_sf.
DR   InterPro; IPR018955; BCDHK/PDK_N.
DR   InterPro; IPR039028; BCKD/PDK.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR005467; His_kinase_dom.
DR   PANTHER; PTHR11947; PTHR11947; 1.
DR   Pfam; PF10436; BCDHK_Adom3; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   SUPFAM; SSF69012; SSF69012; 1.
DR   PROSITE; PS50109; HIS_KIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Carbohydrate metabolism;
KW   Glucose metabolism; Kinase; Mitochondrion; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Transferase; Transit peptide.
FT   TRANSIT         1..28
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255, ECO:0007744|PubMed:25944712"
FT   CHAIN           29..436
FT                   /note="[Pyruvate dehydrogenase (acetyl-transferring)]
FT                   kinase isozyme 1, mitochondrial"
FT                   /id="PRO_0000023437"
FT   DOMAIN          163..393
FT                   /note="Histidine kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00107"
FT   BINDING         279..286
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         318
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         337..338
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         354..359
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         136
FT                   /note="Phosphotyrosine; by FGFR1"
FT                   /evidence="ECO:0000269|PubMed:22195962"
FT   MOD_RES         243
FT                   /note="Phosphotyrosine; by FGFR1, ABL1, FLT3 and JAK2"
FT                   /evidence="ECO:0000269|PubMed:22195962"
FT   MOD_RES         244
FT                   /note="Phosphotyrosine; by FGFR1"
FT                   /evidence="ECO:0000269|PubMed:22195962"
FT   MOD_RES         405
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BFP9"
FT   VAR_SEQ         137
FT                   /note="D -> ERPRRTWLQVSSLCCMACKMI (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.2"
FT                   /id="VSP_055172"
FT   VARIANT         134
FT                   /note="A -> T (in dbSNP:rs35661499)"
FT                   /id="VAR_050477"
FT   VARIANT         412
FT                   /note="N -> T (in dbSNP:rs34250425)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042295"
FT   CONFLICT        8
FT                   /note="R -> L (in Ref. 2; ABB29979)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        96
FT                   /note="L -> R (in Ref. 3; BAH14173)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        363
FT                   /note="R -> C (in Ref. 2; ABB29979)"
FT                   /evidence="ECO:0000305"
FT   HELIX           42..50
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   HELIX           59..67
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   HELIX           72..94
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   HELIX           99..102
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   HELIX           105..122
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   STRAND          125..127
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   HELIX           132..148
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   TURN            149..151
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   HELIX           152..166
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   HELIX           171..202
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   STRAND          219..224
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   HELIX           225..244
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   STRAND          250..259
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   STRAND          265..268
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   HELIX           270..291
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   TURN            293..295
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   STRAND          301..307
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   STRAND          309..318
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   HELIX           325..328
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   HELIX           329..332
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   TURN            334..337
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   STRAND          352..354
FT                   /evidence="ECO:0007829|PDB:2Q8H"
FT   HELIX           358..368
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   STRAND          372..378
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   TURN            379..381
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   STRAND          382..392
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   TURN            393..395
FT                   /evidence="ECO:0007829|PDB:2Q8G"
FT   HELIX           405..411
FT                   /evidence="ECO:0007829|PDB:2Q8G"
SQ   SEQUENCE   436 AA;  49244 MW;  D14CD594E0EA45A2 CRC64;
     MRLARLLRGA ALAGPGPGLR AAGFSRSFSS DSGSSPASER GVPGQVDFYA RFSPSPLSMK
     QFLDFGSVNA CEKTSFMFLR QELPVRLANI MKEISLLPDN LLRTPSVQLV QSWYIQSLQE
     LLDFKDKSAE DAKAIYDFTD TVIRIRNRHN DVIPTMAQGV IEYKESFGVD PVTSQNVQYF
     LDRFYMSRIS IRMLLNQHSL LFGGKGKGSP SHRKHIGSIN PNCNVLEVIK DGYENARRLC
     DLYYINSPEL ELEELNAKSP GQPIQVVYVP SHLYHMVFEL FKNAMRATME HHANRGVYPP
     IQVHVTLGNE DLTVKMSDRG GGVPLRKIDR LFNYMYSTAP RPRVETSRAV PLAGFGYGLP
     ISRLYAQYFQ GDLKLYSLEG YGTDAVIYIK ALSTDSIERL PVYNKAAWKH YNTNHEADDW
     CVPSREPKDM TTFRSA
//
